PAR 4.76% 20.0¢ paradigm biopharmaceuticals limited..

PAR. SP, page-723

  1. 1,549 Posts.
    lightbulb Created with Sketch. 193
    Hi TR

    It’s just a hunch and the realisation that if he fails then it’s a wasted opportunity. We don’t know why Marco left and I am sure with hindsight Paul would have done things differently

    We know the product works, albeit not for everyone

    I suspect that Paul will do a deal which is lower than his previous target

    This is just gut instinct



 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.